Have your own idea? Try our Stock Screener
U.K. (FTSE) Life Sciences Industry Analysis
UpdatedJun 10, 2026
DataAggregated Company Financials
Companies7
- 7D-6.2%
- 3M3.4%
- 1Y0.3%
- YTD0.01%
Over the last 7 days, the Life Sciences industry has dropped 6.2%, driven by Oxford Nanopore Technologies declining 7.6%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the U.K. Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 11 Jun 2026 | UK£1.5b | UK£323.0m | -UK£166,018,254.00 | 1248.2x | -8.8x | 4.5x |
| Sat, 09 May 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -8x | 4.2x |
| Mon, 06 Apr 2026 | UK£1.4b | UK£323.0m | -UK£156,192,254.00 | 8.2x | -8.8x | 4.2x |
| Wed, 04 Mar 2026 | UK£1.3b | UK£324.0m | -UK£161,423,254.00 | 10.4x | -8.2x | 4.1x |
| Fri, 30 Jan 2026 | UK£1.8b | UK£304.6m | -UK£159,441,254.00 | 8x | -11x | 5.8x |
| Sun, 28 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.8x | -9x | 4.7x |
| Tue, 25 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 7.4x | -9.5x | 5.1x |
| Thu, 23 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 9x | -9.8x | 5.3x |
| Sat, 20 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.3x | -11.1x | 5.6x |
| Mon, 18 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14x | 7.7x |
| Wed, 16 Jul 2025 | UK£1.7b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -10.3x | 5.7x |
| Fri, 13 Jun 2025 | UK£1.6b | UK£319.3m | -UK£190,663,434.70 | 7.3x | -8.3x | 4.9x |
| Sun, 11 May 2025 | UK£1.7b | UK£313.2m | -UK£192,933,253.70 | 11.2x | -8.7x | 5.4x |
| Tue, 08 Apr 2025 | UK£1.4b | UK£316.2m | -UK£187,033,235.65 | 5.6x | -7.3x | 4.3x |
| Thu, 06 Mar 2025 | UK£1.4b | UK£321.2m | -UK£182,218,593.52 | 6.8x | -7.9x | 4.5x |
| Sat, 01 Feb 2025 | UK£2.1b | UK£306.9m | -UK£195,557,155.92 | 7.5x | -10.6x | 6.7x |
| Mon, 30 Dec 2024 | UK£1.8b | UK£306.6m | -UK£195,250,541.04 | 7.6x | -9.4x | 6x |
| Wed, 27 Nov 2024 | UK£1.9b | UK£306.7m | -UK£193,121,091.20 | 7.7x | -9.6x | 6x |
| Fri, 25 Oct 2024 | UK£2.0b | UK£304.7m | -UK£192,536,544.40 | 10.9x | -10.5x | 6.6x |
| Sun, 22 Sep 2024 | UK£2.2b | UK£303.8m | -UK£191,679,415.50 | 11.5x | -11.5x | 7.3x |
| Tue, 20 Aug 2024 | UK£1.9b | UK£296.1m | -UK£188,672,625.30 | 12.3x | -10x | 6.4x |
| Thu, 18 Jul 2024 | UK£1.7b | UK£295.0m | -UK£189,507,675.57 | 12.3x | -9.1x | 5.8x |
| Sat, 15 Jun 2024 | UK£1.6b | UK£295.8m | -UK£189,931,418.67 | 11.6x | -8.2x | 5.3x |
| Mon, 13 May 2024 | UK£1.7b | UK£295.1m | -UK£187,865,864.75 | 6797.2x | -8.9x | 5.6x |
| Wed, 10 Apr 2024 | UK£1.7b | UK£317.2m | -UK£178,028,849.39 | 12.2x | -9.4x | 5.3x |
| Fri, 08 Mar 2024 | UK£1.9b | UK£292.9m | -UK£212,421,186.86 | 7034.5x | -8.8x | 6.4x |
| Sun, 04 Feb 2024 | UK£2.8b | UK£450.4m | -UK£176,742,955.00 | 69.8x | -16x | 6.3x |
| Tue, 02 Jan 2024 | UK£3.2b | UK£449.9m | -UK£173,922,769.00 | 56.2x | -18.3x | 7.1x |
| Thu, 30 Nov 2023 | UK£3.1b | UK£455.2m | -UK£168,326,347.00 | 50.5x | -18.2x | 6.7x |
| Sat, 28 Oct 2023 | UK£3.0b | UK£458.8m | -UK£165,732,145.00 | 46.7x | -18x | 6.5x |
| Mon, 25 Sep 2023 | UK£3.1b | UK£447.9m | -UK£167,427,280.00 | 67.5x | -18.3x | 6.8x |
| Wed, 23 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,492,634.00 | 70.6x | -24.7x | 6.6x |
| Fri, 21 Jul 2023 | UK£3.4b | UK£476.3m | -UK£124,508,381.00 | 69.6x | -27.5x | 7.2x |
| Sun, 18 Jun 2023 | UK£3.1b | UK£476.3m | -UK£124,569,758.00 | 64.4x | -24.5x | 6.4x |
Price to Earnings Ratio
-24.5x
Current Industry PE
- Investors are pessimistic on the British Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.5x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -1.85% | |
| Healthcare | 3.47% | |
| Life Sciences | -6.23% | |
| Clinical Research and Equipment | -6.23% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.087 | 4.2% +UK£2.4m | -26.9% | PS1.2x | |
| OBD Oxford BioDynamics | UK£0.0019 | 16.8% +UK£1.2m | -49.9% | PS7.4x |